We merged the data from normal and neoplastic samples from our most cancers individuals using a latest dataset from regular crypts of wholesome patients9, and carried out mutational signature discovery using SparseSignature20, a method that avoids overfitting of signatures by imposing sparsity of the signal (Supplementary Fig. three). We received